$ALVR
AlloVir Inc
PRICE
$7.84 β²0.771%
Last Close
VOLUME
263,585
DAY RANGE
7.65 - 8.4134
52 WEEK
3.17 - 26.41
Key Metrics
Market Cap
761.26 M
Beta
1.70
Avg. Volume
805.63 K
Shares Outstanding
93.06 M
Yield
0%
Public Float
0
Next Earnings Date
2022-11-04
Next Dividend Date
Company Information
AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The companyβs innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVirβs technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
Website: www.allovir.com
HQ: ,
Related News